COMMUNIQUÉS West-GlobeNewswire

-
Change in number of shares and votes in Saniona AB (publ)
28/06/2019 -
Curetis Reports Results of the Annual General Meeting Held on June 27, 2019
28/06/2019 -
Valneva Shareholders Approve all Resolutions Recommended by the Management Board at the Annual General Meeting
28/06/2019 -
Les actionnaires de Valneva approuvent toutes les résolutions recommandées par le directoire à l’Assemblée Générale du Groupe
28/06/2019 -
Oasmia announces change of CEO
28/06/2019 -
The Board of Oasmia has decided to report certain transactions to the Swedish Economic Crime Authority and to appoint a special examiner
28/06/2019 -
Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2018 – April 30, 2019
28/06/2019 -
Progenics Pharmaceuticals Details Recent Good Faith Efforts to Settle with Velan Capital
28/06/2019 -
Allena Pharmaceuticals Announces $10.0 Million Registered Direct Offering of Common Stock
28/06/2019 -
Calciphylaxis Clinical Study Expands to the United Kingdom
28/06/2019 -
United Cannabis Trade Association Support $30,000 Fines Imposed on Unlicensed Operators
28/06/2019 -
Chi-Med Announces Secondary Offering of American Depositary Shares
27/06/2019 -
Cytori Announces New Annual Stockholders Meeting Date for July 11
27/06/2019 -
Evolve Treatment Centers Funds DBT Training for Staff
27/06/2019 -
Globus Medical Appoints Keith Pfeil as Senior Vice President and CFO
27/06/2019 -
Biocryst Begins Enrollment of Phase 1 Trial of BCX9930, an Oral Factor D Inhibitor for Complement-Mediated Diseases
27/06/2019 -
Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled IL-12 with Libtayo® (cemiplimab-rwlc) to Treat Patients with Recurrent Glioblastoma
27/06/2019 -
b-2Cool’s U.S. Strategy Extinguishes Fires to Reshape Native Type II Collagen Market
27/06/2019 -
Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments
27/06/2019
Pages